ᱱᱤᱢᱩᱥᱞᱟᱭᱰ

ᱱᱤᱢᱩᱥᱞᱟᱭᱰ
ᱠᱞᱤᱱᱤᱠᱟᱞ ᱰᱮᱴᱟ
ᱮ.ᱮᱭᱤᱪ.ᱮᱯᱷ.ᱮᱥ/ᱰᱨᱟᱜᱥ.ᱠᱚᱢ	International Drug Names
ᱵᱮᱵᱷᱟᱨ ᱨᱮᱱᱟᱜ; ᱴᱷᱟᱶ	By mouth, rectal, topical
ᱮ.ᱴᱤ.ᱥᱤ ᱠᱳᱰ	M01AX17 (WHO) ᱪᱷᱟᱸᱪ:ATC;
ᱟᱹᱱᱟᱹᱨᱤ ᱦᱟᱞᱚᱛ
ᱟᱹᱱᱟᱹᱨᱤ ᱦᱟᱞᱚᱛ	AU: S4 (Prescription only) ; prescription only;
ᱯᱷᱟᱨᱢᱟᱠᱳᱠᱟᱭᱱᱮᱴᱤᱠ ᱰᱮᱴᱟ
ᱯᱨᱳᱴᱤᱱ ᱛᱚᱱᱚᱞ	>97.5%
ᱢᱮᱴᱟᱵᱳᱞᱤᱡᱚᱢ	Hepatic
ᱵᱟᱹᱜᱤ ᱟᱫᱷᱟ-ᱡᱤᱭᱚᱱ	1.8–4.7h
ᱨᱟᱪᱟᱥᱮᱫ	Renal (50%), fecal (29%)
ᱩᱯᱨᱩᱢᱤᱭᱟᱹ
	ᱟᱭ.ᱭᱩ.ᱯᱤ.ᱮ.ᱥᱤ ᱧᱩᱛᱩᱢ N-(4-Nitro-2-phenoxyphenyl)methanesulfonamide;
ᱥᱤ.ᱮ.ᱮᱥ ᱱᱚᱢᱵᱚᱨ	51803-78-2 ;
ᱯᱟᱵᱽᱠᱮᱢ ᱥᱤ.ᱟᱭ.ᱰᱤ	4495;
ᱟᱭ.ᱭᱩ.ᱯᱤ.ᱮᱭᱤᱪ.ᱮ.ᱟᱨ/ᱵᱤ.ᱯᱤ.ᱮᱥ	7401;
ᱰᱨᱟᱜᱵᱮᱸᱠ	DB04743ᱪᱷᱟᱸᱪ:Drugbankcite;
ᱠᱮᱢᱥᱯᱟᱭᱰᱟᱨ	4339ᱪᱷᱟᱸᱪ:Chemspidercite;
ᱭᱩ.ᱮᱱ.ᱟᱭ.ᱟᱭ	V4TKW1454M;
ᱠᱮ.ᱤ.ᱡᱤ.ᱡᱤ	D01049ᱪᱷᱟᱸᱪ:Keggcite;
ᱥᱤ.ᱮᱭᱤᱪ.ᱤ.ᱵᱤ.ᱟᱭ	CHEBI:44445ᱪᱷᱟᱸᱪ:Ebicite;
ᱥᱤ.ᱮᱭᱤᱪ.ᱤ.ᱮᱢ.ᱵᱤ.ᱮᱞ	ChEMBL56367ᱪᱷᱟᱸᱪ:Ebicite;
ECHA InfoCard	100.052.194
Chemical and physical data
ᱯᱷᱚᱨᱢᱩᱞᱟ	C13H12N2O5S
ᱢᱤᱞᱟᱨ ᱢᱟᱥ	Error in {{val}}: parameter 1 is not a valid number. g·mol−1
ᱛᱷᱨᱤᱰᱤ ᱢᱚᱰᱮᱞ (ᱡᱮ.ᱮᱥ.ᱢᱳᱞ)	Interactive image;
	ᱮᱥ.ᱮᱢ.ᱟᱭ.ᱮᱞ.ᱤ.ᱮᱥ [O-][N+](=O)c2cc(Oc1ccccc1)c(cc2)NS(=O)(=O)C;
	ᱟᱭ.ᱮᱱ.ᱥᱤ.ᱮᱭᱤᱪ.ᱮᱞ InChI=1S/C13H12N2O5S/c1-21(18,19)14-12-8-7-10(15(16)17)9-13(12)20-11-5-3-2-4-6-11/h2-9,14H,1H3ᱪᱷᱟᱸᱪ:Stdinchicite; Key:HYWYRSMBCFDLJT-UHFFFAOYSA-Nᱪᱷᱟᱸᱪ:Stdinchicite;
ᱪᱷᱟᱸᱪ:Cross (what is this?) (verify)

ᱱᱤᱢᱩᱥᱞᱟᱭᱰ ᱫᱚ ᱵᱟᱹᱲᱛᱤ ᱦᱟᱹᱥᱩ ᱠᱚᱣᱟ ᱩᱱ ᱚᱠᱛᱮ ᱱᱚᱶᱟ ᱨᱟᱱ ᱠᱚ ᱡᱚᱢᱟ ᱟᱨ ᱱᱚᱶᱟ ᱫᱚ ᱨᱩᱣᱟᱹᱜ ᱠᱚ ᱠᱚᱢ ᱟᱱᱟᱜ ᱜᱩᱱ ᱥᱟᱶ ᱢᱤᱫ ᱱᱟᱹᱱᱥᱴᱮᱨᱟᱹᱭᱤᱰᱚᱞ ᱮᱱᱴᱤ-ᱤᱱᱯᱷᱞᱮᱢᱮᱴᱚᱨᱤ ᱰᱨᱚᱜᱽ (NSAID) ᱠᱟᱱᱟ ᱾ ᱱᱚᱶᱟ ᱨᱮᱱᱟᱜ ᱯᱩᱨᱟᱹ ᱵᱟᱰᱟᱭ ᱚᱪᱚ ᱫᱚ ᱟᱹᱰᱤ ᱡᱚᱨ ᱜᱮ ᱦᱟᱹᱥᱩ, ᱢᱟᱨᱮᱭᱟᱜ ᱟᱹᱥᱴᱤᱭᱳᱟᱨᱛᱷᱨᱟᱭᱴᱤᱥ ᱨᱮᱱᱟᱜ ᱨᱚᱜᱽ ᱩᱨᱩᱢ ᱴᱨᱤᱴ ᱟᱨ ᱑᱒ ᱵᱚᱭᱚᱥ ᱠᱷᱚᱱ ᱵᱟᱹᱲᱛᱤ ᱩᱢᱮᱨ ᱨᱮᱱ ᱴᱤᱱᱮᱡᱽ ᱠᱚᱣᱟᱜ ᱟᱨ ᱚᱱᱟ ᱠᱷᱚᱱ ᱢᱟᱨᱟᱝ ᱦᱚᱲ ᱨᱮ ᱮᱛᱚᱦᱚᱵ ᱰᱤᱥᱢᱮᱱᱳᱨᱤᱭᱟ ᱨᱮᱱᱟᱜ ᱴᱨᱤᱴ ᱢᱮᱱᱟᱜ-ᱟ ᱾

ᱥᱟᱭᱤᱰ ᱤᱯᱷᱮᱠᱴ ᱨᱮ ᱭᱟᱠᱨᱤᱛ ᱨᱮᱱᱟᱜ ᱠᱚᱥᱴᱚ ᱦᱚᱸ ᱥᱮᱞᱮᱫ ᱦᱩᱭ ᱫᱟᱲᱮᱭᱟᱜ-ᱟ ᱾ ᱱᱚᱶᱟ ᱨᱮ ᱮᱠᱥᱚᱱ ᱦᱟᱛᱟᱣ ᱞᱟᱹᱜᱤᱫ ᱢᱤᱫ ᱵᱟᱦᱩᱭ ᱠᱨᱤᱭᱟᱥᱤᱞ ᱢᱳᱰ ᱢᱮᱱᱟᱜ-ᱟ ᱟᱨ ᱱᱚᱶᱟ ᱨᱮ ᱮᱠᱥᱚᱱ ᱦᱟᱛᱟᱣ ᱨᱮᱱᱟᱜ ᱡᱚᱨ ᱮᱛᱚᱦᱚᱵ ᱨᱮᱱᱟᱜ ᱵᱤᱥᱮᱥ ᱢᱮᱱᱟᱜ-ᱥ ᱾ ᱱᱚᱶᱟ ᱯᱨᱳᱥᱴᱟᱜᱽᱞᱮᱱᱰᱤᱥ (ᱦᱟᱹᱥᱩ ᱥᱟᱶ ᱡᱚᱲᱟᱣ ᱟᱠᱟᱱ ᱢᱤᱫ ᱠᱮᱢᱤᱠᱟᱞ) ᱨᱮᱱᱟᱜ ᱟᱨᱡᱟᱣ ᱚᱣᱨᱤᱫᱷ ᱠᱟᱛᱮ ᱠᱟᱹᱢᱤ ᱮᱫ ᱟᱭ, ᱡᱟᱦᱟᱸ ᱫᱚ ᱦᱟᱹᱥᱩ ᱟᱨ ᱞᱟᱦᱨᱟᱣ ᱠᱷᱚᱱ ᱡᱤᱨᱟᱹᱣ ᱚᱪᱚ ᱮᱫ ᱟᱭ ᱾

ᱢᱮᱰᱤᱠᱮᱥᱚᱱ

ᱢᱮᱰᱤᱠᱟᱞ ᱵᱮᱵᱷᱟᱨ

ᱱᱤᱢᱥᱞᱟᱭᱰ ᱨᱟᱱ ᱭᱩᱱᱟᱭᱴᱮᱰ ᱥᱴᱮᱴ ᱨᱮ ᱵᱮᱵᱚᱥᱛᱟ ᱵᱟᱹᱱᱩᱜ ᱟᱠᱟᱫ-ᱟ, ᱦᱟᱹᱥᱩ ᱠᱷᱚᱱ ᱠᱚᱢᱚᱜ ᱞᱟᱹᱜᱤᱫ ᱭᱩᱱᱟᱭᱴᱮᱰ ᱥᱴᱮᱴ ᱪᱷᱟᱲᱟ ᱥᱟᱱᱟᱢ ᱫᱤᱥᱚᱢ ᱨᱮᱜᱮ ᱠᱚ ᱵᱮᱵᱷᱟᱨ ᱮᱫ ᱜᱮᱭᱟ ᱾^[᱑] ᱱᱚᱶᱟ ᱱᱤᱢᱥᱞᱟᱭᱰ ᱨᱟᱱ ᱫᱚ ᱡᱟᱦᱟᱸᱭ ᱠᱚ ᱯᱤᱨᱤᱭᱟᱰ ᱯᱮᱭᱱ ᱦᱟᱹᱥᱩ ᱦᱩᱭ ᱟᱠᱚ ᱠᱟᱱᱟ ᱩᱱᱠᱩ ᱱᱚᱶᱟ ᱨᱟᱱ ᱠᱚ ᱡᱚᱢ ᱫᱟᱲᱮᱭᱟᱜ-ᱟ ᱾ ᱱᱤᱢᱥᱞᱟᱭᱰ ᱫᱚ ᱞᱳᱝ ᱴᱚᱨᱢ ᱟᱱᱟᱜ ᱫᱚ ᱵᱟᱝ ᱠᱟᱱᱟ ᱱᱚᱶᱟ ᱫᱚ ᱠᱨᱚᱱᱤᱠ ᱠᱚᱱᱰᱤᱥᱚᱱ ᱡᱮᱞᱮᱠᱟ ᱟᱨᱛᱷᱨᱟᱭᱴᱤᱥ ᱾

ᱥᱟᱹᱠᱷᱭᱟᱹᱛ

↑ "Nimesulide". livertox.nih.gov. Archived from the original on 23 December 2017. Retrieved 22 December 2017.

[Liv2017-1] "Nimesulide". livertox.nih.gov. Archived from the original on 23 December 2017. Retrieved 22 December 2017.

[᱑]

ᱠᱞᱤᱱᱤᱠᱟᱞ ᱰᱮᱴᱟ

ᱮ.ᱮᱭᱤᱪ.ᱮᱯᱷ.ᱮᱥ/ᱰᱨᱟᱜᱥ.ᱠᱚᱢ	International Drug Names
ᱵᱮᱵᱷᱟᱨ ᱨᱮᱱᱟᱜ ᱴᱷᱟᱶ	By mouth, rectal, topical
ᱮ.ᱴᱤ.ᱥᱤ ᱠᱳᱰ	M01AX17 (WHO) ᱪᱷᱟᱸᱪ:ATC
ᱟᱹᱱᱟᱹᱨᱤ ᱦᱟᱞᱚᱛ
ᱟᱹᱱᱟᱹᱨᱤ ᱦᱟᱞᱚᱛ	AU: S4 (Prescription only) prescription only
ᱯᱷᱟᱨᱢᱟᱠᱳᱠᱟᱭᱱᱮᱴᱤᱠ ᱰᱮᱴᱟ
ᱯᱨᱳᱴᱤᱱ ᱛᱚᱱᱚᱞ	>97.5%
ᱢᱮᱴᱟᱵᱳᱞᱤᱡᱚᱢ	Hepatic
ᱵᱟᱹᱜᱤ ᱟᱫᱷᱟ-ᱡᱤᱭᱚᱱ	1.8–4.7h
ᱨᱟᱪᱟᱥᱮᱫ	Renal (50%), fecal (29%)
ᱩᱯᱨᱩᱢᱤᱭᱟᱹ
ᱟᱭ.ᱭᱩ.ᱯᱤ.ᱮ.ᱥᱤ ᱧᱩᱛᱩᱢ N-(4-Nitro-2-phenoxyphenyl)methanesulfonamide
ᱥᱤ.ᱮ.ᱮᱥ ᱱᱚᱢᱵᱚᱨ	51803-78-2^Y
ᱯᱟᱵᱽᱠᱮᱢ ᱥᱤ.ᱟᱭ.ᱰᱤ	4495
ᱟᱭ.ᱭᱩ.ᱯᱤ.ᱮᱭᱤᱪ.ᱮ.ᱟᱨ/ᱵᱤ.ᱯᱤ.ᱮᱥ	7401
ᱰᱨᱟᱜᱵᱮᱸᱠ	DB04743ᱪᱷᱟᱸᱪ:Drugbankcite
ᱠᱮᱢᱥᱯᱟᱭᱰᱟᱨ	4339ᱪᱷᱟᱸᱪ:Chemspidercite
ᱭᱩ.ᱮᱱ.ᱟᱭ.ᱟᱭ	V4TKW1454M
ᱠᱮ.ᱤ.ᱡᱤ.ᱡᱤ	D01049ᱪᱷᱟᱸᱪ:Keggcite
ᱥᱤ.ᱮᱭᱤᱪ.ᱤ.ᱵᱤ.ᱟᱭ	CHEBI:44445ᱪᱷᱟᱸᱪ:Ebicite
ᱥᱤ.ᱮᱭᱤᱪ.ᱤ.ᱮᱢ.ᱵᱤ.ᱮᱞ	ChEMBL56367ᱪᱷᱟᱸᱪ:Ebicite
ECHA InfoCard	100.052.194
Chemical and physical data
ᱯᱷᱚᱨᱢᱩᱞᱟ	C₁₃H₁₂N₂O₅S
ᱢᱤᱞᱟᱨ ᱢᱟᱥ	Error in {{val}}: parameter 1 is not a valid number. g·mol⁻¹
ᱛᱷᱨᱤᱰᱤ ᱢᱚᱰᱮᱞ (ᱡᱮ.ᱮᱥ.ᱢᱳᱞ)	Interactive image
ᱮᱥ.ᱮᱢ.ᱟᱭ.ᱮᱞ.ᱤ.ᱮᱥ [O-][N+](=O)c2cc(Oc1ccccc1)c(cc2)NS(=O)(=O)C
ᱟᱭ.ᱮᱱ.ᱥᱤ.ᱮᱭᱤᱪ.ᱮᱞ InChI=1S/C13H12N2O5S/c1-21(18,19)14-12-8-7-10(15(16)17)9-13(12)20-11-5-3-2-4-6-11/h2-9,14H,1H3ᱪᱷᱟᱸᱪ:Stdinchicite Key:HYWYRSMBCFDLJT-UHFFFAOYSA-Nᱪᱷᱟᱸᱪ:Stdinchicite
^{ᱪᱷᱟᱸᱪ:CrossY} (what is this?) (verify)